For example, the concentration of ULBP2 in serum appears to be associated with poor survival in melanoma, B-cell chronic lymphocytic leukemia and lung cancer patients, and therefore it can be a marker for tumor load [10]–[13]. Here, ULBP2 is linked to melanoma.